BeStock  
股票 › MNKD

曼恩凯德制药 MNKD

美股市值排名 #3070
$3.90 +$0.14 (+3.72%)
休市 · Nov 6, 8:20 pm ET · 最新盘后价 $3.85 -1.28%
开盘$3.92
昨收$3.76
当日区间$3.80 – $4.09
成交量4.99M
市值$1.25B
市盈率(TTM)–
股息率–

MNKD 相关新闻

匹配 MannKind 或代码 MNKD 的头条新闻,按最新排序。

  • MannKind | 4: Statement of changes in beneficial ownership of securities-Director Binder Steven B.SEC · 29 Sep 2026 · 相关
  • MannKind | 144: Notice of proposed sale of securities pursuant to Rule 144SEC · 26 Sep 2026 · 相关
  • H.C. Wainwright Maintains MannKind(MNKD.US) With Buy Rating, Maintains Target Price $10Market news · 22 Sep 2026 · 直接提及
  • H.C. Wainwright Keeps Their Buy Rating on MannKind (MNKD)TipRanks · 22 Sep 2026 · 直接提及
  • Wells Fargo Maintains MannKind(MNKD.US) With Buy Rating, Maintains Target Price $13Market news · 2 Sep 2026 · 直接提及
  • MannKind | 4: Statement of changes in beneficial ownership of securities-Director Binder Steven B.SEC · 15 Sep 2026 · 相关
  • MannKind | 144: Notice of proposed sale of securities pursuant to Rule 144SEC · 11 Sep 2026 · 相关
  • Cantor Fitzgerald Maintains MannKind(MNKD.US) With Buy Rating, Maintains Target Price $8Market news · 11 Sep 2026 · 直接提及
  • Truist Financial Maintains MannKind(MNKD.US) With Buy RatingMarket news · 10 Sep 2026 · 直接提及
  • Cantor Fitzgerald Maintains MannKind(MNKD.US) With Buy Rating, Cuts Target Price to $8 负面Market news · 6 Aug 2026 · 直接提及
  • A Quick Look at Today's Ratings for MannKind(MNKD.US), With a Forecast Between $4.75 to $13Market news · 6 Aug 2026 · 直接提及
  • MannKind | 8-K: Current reportSEC · 22 Aug 2026 · 相关
  • Wedbush Maintains MannKind(MNKD.US) With Buy Rating, Maintains Target Price $8Market news · 30 Jul 2026 · 直接提及
  • Wells Fargo Maintains MannKind(MNKD.US) With Buy Rating, Raises Target Price to $14 正面Market news · 30 Jul 2026 · 直接提及
  • Analysts Offer Insights on Healthcare Companies: MannKind (MNKD), Bruker (BRKR) and BrightSpring Health Services, Inc. (BTSG)TipRanks · 27 Jul 2026 · 直接提及

讨论区

暂无评论——快来第一个聊聊 MNKD。

发表评论

Scroll to Top